UniProt ID | TMM43_HUMAN | |
---|---|---|
UniProt AC | Q9BTV4 | |
Protein Name | Transmembrane protein 43 | |
Gene Name | TMEM43 | |
Organism | Homo sapiens (Human). | |
Sequence Length | 400 | |
Subcellular Localization |
Endoplasmic reticulum. Nucleus inner membrane Multi-pass membrane protein. Retained in the inner nuclear membrane through interaction with EMD and A- and B-lamins. The N- and C-termini are oriented towards the nucleoplasm. The majority of the hydrop |
|
Protein Description | May have an important role in maintaining nuclear envelope structure by organizing protein complexes at the inner nuclear membrane. Required for retaining emerin at the inner nuclear membrane (By similarity).. | |
Protein Sequence | MAANYSSTSTRREHVKVKTSSQPGFLERLSETSGGMFVGLMAFLLSFYLIFTNEGRALKTATSLAEGLSLVVSPDSIHSVAPENEGRLVHIIGALRTSKLLSDPNYGVHLPAVKLRRHVEMYQWVETEESREYTEDGQVKKETRYSYNTEWRSEIINSKNFDREIGHKNPSAMAVESFMATAPFVQIGRFFLSSGLIDKVDNFKSLSLSKLEDPHVDIIRRGDFFYHSENPKYPEVGDLRVSFSYAGLSGDDPDLGPAHVVTVIARQRGDQLVPFSTKSGDTLLLLHHGDFSAEEVFHRELRSNSMKTWGLRAAGWMAMFMGLNLMTRILYTLVDWFPVFRDLVNIGLKAFAFCVATSLTLLTVAAGWLFYRPLWALLIAGLALVPILVARTRVPAKKLE | |
Overview of Protein Modification Sites with Functional and Structural Information | ||
* ASA = Accessible Surface Area
Locations | Modification | Substrate Peptides & Secondary Structure |
ASA (%) | Reference | Orthologous Protein Cluster |
---|---|---|---|---|---|
2 | Acetylation | ------MAANYSSTS ------CCCCCCCCC | 12.38 | 25732826 | |
5 | Phosphorylation | ---MAANYSSTSTRR ---CCCCCCCCCCCC | 10.16 | 28796482 | |
6 | Phosphorylation | --MAANYSSTSTRRE --CCCCCCCCCCCCC | 27.26 | 23401153 | |
7 | Phosphorylation | -MAANYSSTSTRREH -CCCCCCCCCCCCCC | 18.93 | 23401153 | |
8 | Phosphorylation | MAANYSSTSTRREHV CCCCCCCCCCCCCCE | 28.33 | 23401153 | |
9 | Phosphorylation | AANYSSTSTRREHVK CCCCCCCCCCCCCEE | 23.12 | 28355574 | |
10 | Phosphorylation | ANYSSTSTRREHVKV CCCCCCCCCCCCEEE | 33.56 | 23401153 | |
18 | Malonylation | RREHVKVKTSSQPGF CCCCEEEECCCCCCH | 36.65 | 32601280 | |
19 | Phosphorylation | REHVKVKTSSQPGFL CCCEEEECCCCCCHH | 36.28 | 23312004 | |
20 | Phosphorylation | EHVKVKTSSQPGFLE CCEEEECCCCCCHHH | 22.66 | 22496350 | |
21 | Phosphorylation | HVKVKTSSQPGFLER CEEEECCCCCCHHHH | 45.70 | 23312004 | |
60 | Phosphorylation | NEGRALKTATSLAEG CCCHHHHHHHHHHCC | 35.70 | - | |
99 | Ubiquitination | IGALRTSKLLSDPNY HHHHHHHHHCCCCCC | 53.48 | 21890473 | |
102 | Phosphorylation | LRTSKLLSDPNYGVH HHHHHHCCCCCCCCC | 62.55 | - | |
114 | Ubiquitination | GVHLPAVKLRRHVEM CCCCCHHHHHHHHHH | 38.08 | - | |
122 | Phosphorylation | LRRHVEMYQWVETEE HHHHHHHHEEECCHH | 5.92 | 29759185 | |
127 | Phosphorylation | EMYQWVETEESREYT HHHEEECCHHHHCCC | 35.12 | 29759185 | |
131 | Methylation | WVETEESREYTEDGQ EECCHHHHCCCCCCC | 44.19 | 115918637 | |
159 | 2-Hydroxyisobutyrylation | RSEIINSKNFDREIG HHHHHHCCCCCCCCC | 58.08 | - | |
159 | Ubiquitination | RSEIINSKNFDREIG HHHHHHCCCCCCCCC | 58.08 | - | |
181 | Phosphorylation | AVESFMATAPFVQIG HHHHHHHCCCHHHHH | 24.07 | 30257219 | |
193 | Phosphorylation | QIGRFFLSSGLIDKV HHHHHHHHCCCCCCC | 19.73 | 28674151 | |
194 | Phosphorylation | IGRFFLSSGLIDKVD HHHHHHHCCCCCCCC | 39.50 | 28674151 | |
199 | Acetylation | LSSGLIDKVDNFKSL HHCCCCCCCCCCCCC | 44.48 | 26051181 | |
199 | 2-Hydroxyisobutyrylation | LSSGLIDKVDNFKSL HHCCCCCCCCCCCCC | 44.48 | - | |
199 | Ubiquitination | LSSGLIDKVDNFKSL HHCCCCCCCCCCCCC | 44.48 | - | |
204 | 2-Hydroxyisobutyrylation | IDKVDNFKSLSLSKL CCCCCCCCCCCHHHC | 57.66 | - | |
204 | Ubiquitination | IDKVDNFKSLSLSKL CCCCCCCCCCCHHHC | 57.66 | - | |
205 | Phosphorylation | DKVDNFKSLSLSKLE CCCCCCCCCCHHHCC | 21.03 | 26437602 | |
207 | Phosphorylation | VDNFKSLSLSKLEDP CCCCCCCCHHHCCCC | 37.37 | 24719451 | |
209 | Phosphorylation | NFKSLSLSKLEDPHV CCCCCCHHHCCCCCC | 31.64 | 20068231 | |
210 | Ubiquitination | FKSLSLSKLEDPHVD CCCCCHHHCCCCCCC | 62.28 | - | |
210 | Acetylation | FKSLSLSKLEDPHVD CCCCCHHHCCCCCCC | 62.28 | 26051181 | |
232 | Acetylation | FYHSENPKYPEVGDL CCCCCCCCCCCCCCE | 82.25 | 26051181 | |
232 | Ubiquitination | FYHSENPKYPEVGDL CCCCCCCCCCCCCCE | 82.25 | 21890473 | |
233 | Phosphorylation | YHSENPKYPEVGDLR CCCCCCCCCCCCCEE | 13.09 | - | |
244 | Phosphorylation | GDLRVSFSYAGLSGD CCEEEEEEECCCCCC | 13.43 | - | |
249 | Phosphorylation | SFSYAGLSGDDPDLG EEEECCCCCCCCCCC | 38.98 | - | |
268 | Methylation | VTVIARQRGDQLVPF EEEEEECCCCEEEEE | 45.14 | 115918641 | |
278 | Ubiquitination | QLVPFSTKSGDTLLL EEEEEECCCCCEEEE | 51.77 | - | |
282 | Phosphorylation | FSTKSGDTLLLLHHG EECCCCCEEEEEECC | 23.88 | - | |
292 | Phosphorylation | LLHHGDFSAEEVFHR EEECCCCCHHHHHHH | 39.24 | - | |
307 | Ubiquitination | ELRSNSMKTWGLRAA HHHHCCCCHHHHHHH | 40.73 | - |
Modified Location | Modified Residue | Modification | Type of Upstream Proteins | Gene Name of Upstream Proteins | UniProt AC of Upstream Proteins | Sources |
---|---|---|---|---|---|---|
Oops, there are no upstream regulatory protein records of TMM43_HUMAN !! |
Modified Location | Modified Residue | Modification | Function | Reference | ||
---|---|---|---|---|---|---|
Oops, there are no descriptions of PTM sites of TMM43_HUMAN !! |
* Distance = the distance between SAP position and PTM sites.
Modified Location | Modification | Variant Position (Distance <= 10) |
Residue Change | SAP | Related Disease | Reference |
---|---|---|---|---|---|---|
Oops, there are no SNP-PTM records of TMM43_HUMAN !! |
Interacting Protein | Gene Name | Interaction Type | PPI Reference | Domain-Domain Interactions |
---|---|---|---|---|
FDFT_HUMAN | FDFT1 | physical | 16169070 | |
VATE1_HUMAN | ATP6V1E1 | physical | 22939629 | |
CUL4B_HUMAN | CUL4B | physical | 26186194 | |
CUL4B_HUMAN | CUL4B | physical | 28514442 |
Kegg Disease | ||||||
---|---|---|---|---|---|---|
H00293 | Arrhythmogenic right ventricular cardiomyopathy (ARVC) | |||||
OMIM Disease | ||||||
604400 | Arrhythmogenic right ventricular dysplasia, familial, 5 (ARVD5) | |||||
614302 | Emery-Dreifuss muscular dystrophy 7, autosomal dominant (EDMD7) | |||||
Kegg Drug | ||||||
There are no disease associations of PTM sites. | ||||||
DrugBank | ||||||
There are no disease associations of PTM sites. |
loading...
Acetylation | |
Reference | PubMed |
"Lys-N and trypsin cover complementary parts of the phosphoproteome ina refined SCX-based approach."; Gauci S., Helbig A.O., Slijper M., Krijgsveld J., Heck A.J.,Mohammed S.; Anal. Chem. 81:4493-4501(2009). Cited for: ACETYLATION [LARGE SCALE ANALYSIS] AT ALA-2, AND MASS SPECTROMETRY. |